Skip to content

Clinical trials

Observational Retinoblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinoblastoma Phase: Observational Country / region: United States Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20102
20121
20141
20172
20182
20191
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting7
Completed5
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Memorial Sloan Kettering Cancer Center3
St. Jude Children's Research Hospital3
Children's Oncology Group2
National Cancer Institute (NCI)2
Children's Hospital Los Angeles1
RTI International1
Stanford University1
University of Washington1
Vanderbilt-Ingram Cancer Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinoblastoma15
Neuroblastoma4
Sarcoma4
Rhabdomyosarcoma3
Melanoma2
Neoplasms2
Osteosarcoma2
Sarcoma, Ewing2
Adenomatous Polyposis Coli1
Adrenocortical Carcinoma1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.